Tyler E. Papp

1.3k citations
17 papers · 593 · 3 hit papers · h-index 9

Impact in

    • RNA Interference and Gene Delivery
    • Advanced biosensing and bioanalysis techniques
    • CRISPR and Genetic Engineering
    • Virus-based gene therapy research

Papers in

    • RNA Interference and Gene Delivery 8
    • Retinal Development and Disorders 4
    • CRISPR and Genetic Engineering 3
    • Advanced biosensing and bioanalysis techniques 2
    • RNA regulation and disease 1
    • Virus-based gene therapy research 5

Tyler E. Papp

14 papers receiving 582 citations

Tyler E. Papp's Hit Papers

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism 2023 · 108 citations
1080+1+3Years since publication50100150

Peers

Tyler E. Papp
Comparison fields: 5 of 58
  • Molecular Biology 442
  • Genetics 162
  • Oncology 157
  • Immunology 101
  • Biomaterials 41
Replace Laura Riolobos with:
Laura Riolobos Spain
Germán G. Gornalusse United States
Xiang Ao China
Juliane W. Schott Germany
Lauren E. Mays United States
Christos Georgiadis United Kingdom
Nigel Parker Finland
Anais K. Amaya Australia
Conrad A. Vink United Kingdom
Michael J. Torres United States
Tyler E. Papp relative to Laura Riolobos Spain Laura Riolobos's profile →
Citations per field
00.5×4.8×
Laura Riolobos · 1×
Citations per year

Countries citing papers authored by Tyler E. Papp

Since Specialization
Citations

This map shows the geographic impact of Tyler E. Papp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler E. Papp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler E. Papp more than expected).

Fields of papers citing papers by Tyler E. Papp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler E. Papp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler E. Papp. The network helps show where Tyler E. Papp may publish in the future.

Co-authors

The 25 scholars most cited alongside Tyler E. Papp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tyler E. Papp Line = papers co-authored together Tyler E. Papp links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
Hit paper breakdown →
2021183
2
In vivo hematopoietic stem cell modification by mRNA delivery
Hit paper breakdown →
2023176
3
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
Hit paper breakdown →
2023108
4 202426
5 201926
6 202424
7 201913
8 202411
9 20199
10 20257
11 20187
12 20251
13 20251
14 20221
15 20260
16 20240
17 20260

About Tyler E. Papp

Tyler E. Papp is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Infectious Diseases, having authored 17 papers that have together received 593 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (5 papers), CAR-T cell therapy research (4 papers), Retinal Development and Disorders (4 papers), CRISPR and Genetic Engineering (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Immunotherapy and Immune Responses (2 papers) and RNA regulation and disease (1 paper). The work is most often cited by research in Molecular Biology (442 citations), Genetics (162 citations), Oncology (157 citations), Immunology (101 citations) and Biomaterials (41 citations). Tyler E. Papp has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Hamideh Parhiz, Drew Weissman, Barbara L. Mui, Amir Yadegari, Ying K. Tam, Mohamad‐Gabriel Alameh, Hamna Shahnawaz, Vladimir R. Muzykantov, Vladimir V. Shuvaev and István Tombácz. Their work appears in journals such as Molecular Therapy, Blood, Science Translational Medicine, British Journal of Ophthalmology and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact